Company Announcements

In January, Anton Paar opened subsidiaries in Poland, South Africa and Brazil. Microwave synthesis and Petrotest products will continue to be distributed in Poland by Comef and Tusnovics, respectively. The South African subsidiary is a joint venture with sales partner Swiss Lab.

In January, AMETEK Advanced Measurement Technology acquired Sunpower, a developer of Stirling cycle cryocoolers and externally heated Stirling cycle engines, stating that the acquisition provides enabling technology for use in its ORTEC Detective family of portable radiation identifiers.

Pall announced in January the expansion of its Menlo Park, California, facility, the site of ForteBio, to create a Center of Excellence for Instrumentation, which will focus on instrumentation and process monitoring system design and development. Also, the Global Instrumentation Field Group now operates from the site.

In January, PAC announced that Daniel Benitez was named vice president of the Process Analytics group.

Oxford Instruments appointed Thomas Geitner, chairman of Bibliotheca RFID Library Systems, to its Board in January.

MOCON named Board member Don DeMorett to the newly created position of COO in January. He is president and CEO of GearGrid.

GE Healthcare announced that fourth-quarter 2012 Life Sciences revenue rose 5%.

In 2012, Teledyne Technologies’ Environmental Instrumentation revenue grew 2.6% to $250.2 million to make up 33% of Instrumentation segment sales.

Lonza Bioscience reported that 2012 Research and Testing Solutions sales grew slightly, but were below expectations due to the weak economic environment in the US and Europe. Research product sales were higher, including growing demand for induced pluripotent stem cell technology. The Molecular Biology business was under margin and volume pressure.

Xylem announced in January a $158 million financing agreement with the European Investment Bank to fund R&D projects for water transport, treatment and analytics across Europe. The funds will be available in 2013–2014 as loans.

Hitachi High-Technologies’ fiscal third quarter Science and Medical Systems (SMS) sales fell 38.8% to ¥24.1 billion ($296.5 million = ¥81.27 = $1). Sales of Clinical Analyzers, and Biotechnology and Other products contracted 49.6% and 26.3% to account for 49% and 17% of SMS sales, respectively. Sales of Electron Microscopes and Analytical Instruments declined 18.3% and 28.6% to account for 24% and 10%, respectively. SMS operating profit fell 85.7% to ¥900 million ($11.1 million). For fiscal 2013, SMS’s revenue outlook was lowered 1% to ¥129.7 billion ($1,553.3 million) and operating profit outlook was trimmed by 17% to ¥12.2 billion ($146.1 million).